Here’s What the Street Thinks About Addus HomeCare (ADUS)

Core Viewpoint - Addus HomeCare Corporation (NASDAQ:ADUS) is recognized as an overlooked small-cap stock with positive sentiment from Wall Street ahead of its fiscal Q4 2025 earnings report, expected to show approximately $372.87 million in revenue and a GAAP EPS of $1.56 [1] Group 1: Analyst Ratings and Price Targets - Clarke Murphy from Truist Financial initiated coverage on Addus HomeCare with a Buy rating and a price target of $135 [2] - Joanna Gajuk from Bank of America Securities reiterated a Buy rating with a price target of $147 [2] Group 2: Growth Drivers and Strategic Focus - Analysts at Bank of America noted that the positive rating is supported by multiple growth drivers, including expected rate increases in Texas, which align with management's mid-to-high single-digit organic growth target for Personal Care [4] - The company is experiencing hiring momentum, which is anticipated to increase turnover rates, further supporting growth [4] - Addus's strategic focus on Personal Care acquisitions positions it well for future expansion [4] Group 3: Business Segments - Addus HomeCare provides in-home care services across three main segments: Personal Care, Hospice, and Home Health [5]